gefitinib
Generic: gefitinib
Labeler: teva pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
gefitinib
Generic Name
gefitinib
Labeler
teva pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
gefitinib 250 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0480-4053
Product ID
0480-4053_94ce2dc4-2b69-4c50-b53e-21e24062903d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208913
Listing Expiration
2026-12-31
Marketing Start
2023-06-21
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04804053
Hyphenated Format
0480-4053
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gefitinib (source: ndc)
Generic Name
gefitinib (source: ndc)
Application Number
ANDA208913 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (0480-4053-56)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "94ce2dc4-2b69-4c50-b53e-21e24062903d", "openfda": {"nui": ["N0000175605", "N0000175076"], "upc": ["0304804053560"], "unii": ["S65743JHBS"], "rxcui": ["349472"], "spl_set_id": ["3dd135f0-5db1-4236-9756-04533b66dc9d"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0480-4053-56)", "package_ndc": "0480-4053-56", "marketing_start_date": "20230621"}], "brand_name": "Gefitinib", "product_id": "0480-4053_94ce2dc4-2b69-4c50-b53e-21e24062903d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "0480-4053", "generic_name": "Gefitinib", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gefitinib", "active_ingredients": [{"name": "GEFITINIB", "strength": "250 mg/1"}], "application_number": "ANDA208913", "marketing_category": "ANDA", "marketing_start_date": "20230621", "listing_expiration_date": "20261231"}